Cargando…

Long non-coding RNA SNHG16 as a potential biomarker in hepatocellular carcinoma: A meta-analysis

Small nucleolar RNA host gene 16 (SNHG16) has recently been reported as a potential biomarker in various cancers. However, the prognostic value of SNHG16 in hepatocellular carcinoma (HCC) has not been investigated yet. Therefore, the purpose of this study was to reveal the association between SNHG16...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Qiuli, Gao, Po, Li, Qingling, Xu, Chao, Qu, Kai, Zhang, Jie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2021
Materias:	4500
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8428724/ https://www.ncbi.nlm.nih.gov/pubmed/34516515 http://dx.doi.org/10.1097/MD.0000000000027178

Ejemplares similares

The Prognostic Value of Platelet Count in Patients With Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis
por: Pang, Qing, et al.
Publicado: (2015)

Metabolomic biomarkers for hepatocellular carcinoma: A systematic review
por: Feng, Ningning, et al.
Publicado: (2022)

p16 Methylation was associated with the development, age, hepatic viruses infection of hepatocellular carcinoma, and p16 expression had a poor survival: A systematic meta-analysis (PRISMA)
por: Lv, Xueyou, et al.
Publicado: (2017)

Value of anti-p53 antibody as a biomarker for hepatocellular carcinoma: Evidence from a meta-analysis
por: Chang, Yue, et al.
Publicado: (2020)

Radiofrequency ablation versus microwave ablation for early stage hepatocellular carcinoma: A PRISMA-compliant systematic review and meta-analysis
por: Han, Jie, et al.
Publicado: (2020)

Effects of hepatic arterial infusion chemotherapy in the treatment of hepatocellular carcinoma: A meta-analysis
por: Long, Guan-Bao, et al.
Publicado: (2020)

Hepatocellular carcinoma after the Fontan procedure in a 16-year-old girl: A case report
por: Oh, Chaeyoun, et al.
Publicado: (2016)

Combination therapy: Meta-analysis of the effects of TACE and cryoablation on hepatocellular carcinoma
por: Yuan-Dong, Sun, et al.
Publicado: (2019)

MRGBP is a potential novel prognostic biomarker and is correlated with immune infiltrates in hepatocellular carcinoma
por: Huang, Juanjun, et al.
Publicado: (2021)

AFP-L3 for the diagnosis of early hepatocellular carcinoma: A meta-analysis
por: Zhou, Jian-Ming, et al.
Publicado: (2021)

The effectiveness of tivantinib for MET-high hepatocellular carcinoma: A protocol for meta analysis
por: Wang, Yubin, et al.
Publicado: (2023)

Circulating MicroRNAs as Biomarkers in Hepatocellular Carcinoma Screening: A Validation Set From China
por: Jiang, Li, et al.
Publicado: (2015)

The association between pretreatment serum alkaline phosphatase and prognosis in hepatocellular carcinoma: A meta-analysis
por: Sun, Ping, et al.
Publicado: (2020)

Evaluation of plasma D-dimer for the diagnosis in Chinese patients with hepatocellular carcinoma: A meta-analysis
por: Fang, Ping, et al.
Publicado: (2020)

Association of interleukin-6 gene polymorphisms with the risk of hepatocellular carcinoma: An up-to-date meta-analysis
por: An, Pei-Pei, et al.
Publicado: (2020)

HAIC versus TACE for patients with unresectable hepatocellular carcinoma: A systematic review and meta-analysis
por: Liu, Junguo, et al.
Publicado: (2022)

Hypomethylation of the cyclin D1 promoter in hepatitis B virus-associated hepatocellular carcinoma
por: Liu, Hui-Hui, et al.
Publicado: (2020)

Effects of RAGE Gene Polymorphisms on the Risk and Progression of Hepatocellular Carcinoma
por: Su, Shih-Chi, et al.
Publicado: (2015)

The Association Between Body Mass Index and the Prognosis and Postoperative Complications of Hepatocellular Carcinoma: A Meta-Analysis
por: Rong, Xiaoxiang, et al.
Publicado: (2015)

Prognostic Role of Glasgow Prognostic Score in Patients With Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis
por: Li, Mu-xing, et al.
Publicado: (2015)

Uncompromised Treatment Efficacy in Elderly Patients With Hepatocellular Carcinoma: A Propensity Score Analysis
por: Liu, Po-Hong, et al.
Publicado: (2014)

Pre-S deletions of hepatitis B virus predict recurrence of hepatocellular carcinoma after curative resection
por: Li-Shuai, Qu, et al.
Publicado: (2017)

Meta-analysis of possible role of cadherin gene methylation in evolution and prognosis of hepatocellular carcinoma with a PRISMA guideline
por: Zhu, Chunxiao, et al.
Publicado: (2017)

Associations between methylenetetrahydrofolate reductase polymorphisms and hepatocellular carcinoma risk: An update meta-analysis and trial sequential analysis
por: Wang, Binfeng, et al.
Publicado: (2021)

Risk factors of infection after transarterial chemoembolization for hepatocellular carcinoma: A protocol for systematic review and meta-analysis
por: Shi, Zhipeng, et al.
Publicado: (2021)

Thymalfasin, a promising adjuvant therapy in small hepatocellular carcinoma after liver resection
por: He, Chao, et al.
Publicado: (2017)

Association of Histone Methyltransferase G9a and Overall Survival After Liver Resection of Patients With Hepatocellular Carcinoma With a Median Observation of 40 Months
por: Bai, Kai, et al.
Publicado: (2016)

Lymphoepithelioma-like hepatocellular carcinoma: A case report and brief review of literature
por: Wang, Jun-Ke, et al.
Publicado: (2017)

Limitation of non-transplant treatment and proper timing for liver transplantation in patients with hepatocellular carcinoma considering long-term survival
por: Nomura, Aya, et al.
Publicado: (2020)

Hepatocellular Carcinoma Patients With Performance Status 1 Deserve New Classification and Treatment Algorithm in the BCLC System
por: Hsu, Chia-Yang, et al.
Publicado: (2015)

Three polymorphisms of tumor necrosis factor-alpha and hepatitis B virus related hepatocellular carcinoma: A meta-analysis
por: Xiao, Qi, et al.
Publicado: (2016)

Prognostic impact of elevated pre-treatment systemic immune-inflammation index (SII) in hepatocellular carcinoma: A meta-analysis
por: Wang, Bolin, et al.
Publicado: (2020)

Synchronous double primary hepatocellular carcinoma and intrahepatic cholangiocarcinoma: A case report and review of the literature
por: Qu, Meng-Meng, et al.
Publicado: (2021)

Pretreatment Neutrophil–Lymphocyte Ratio: An Independent Predictor of Survival in Patients With Hepatocellular Carcinoma
por: Gao, Fangyuan, et al.
Publicado: (2015)

Association between ABO blood group and HCV-related hepatocellular carcinoma risk in China
por: Li, Xu, et al.
Publicado: (2016)

Hepatic Resection for Hepatocellular Carcinoma in Patients With Portal Hypertension: A Long-Term Benefit Compared With Transarterial Chemoembolization and Thermal Ablation
por: Xiao, Hua, et al.
Publicado: (2015)

Comparative Efficacy of Interventional Therapies for Early-stage Hepatocellular Carcinoma: A PRISMA-compliant Systematic Review and Network Meta-analysis
por: Lan, Tian, et al.
Publicado: (2016)

Trans-catheter arterial chemoembolization plus Sorafenib, an unsuccessful therapy in the treatment of hepatocellular carcinoma?: A systematic review and meta-analysis
por: Zhang, Tao, et al.
Publicado: (2020)

Survival comparison between radiofrequency ablation and surgical resection for patients with small hepatocellular carcinoma: A systematic review and meta-analysis
por: Xuan, Dongchun, et al.
Publicado: (2021)

Diabetes mellitus increases the risk of hepatocellular carcinoma in treatment-naïve chronic hepatitis C patients in China
por: Li, Xu, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_rt2ffds4fc7k803maqki388gaq